77 related articles for article (PubMed ID: 2332631)
21. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha.
Satoh J; Seino H; Shintani S; Tanaka S; Ohteki T; Masuda T; Nobunaga T; Toyota T
J Immunol; 1990 Sep; 145(5):1395-9. PubMed ID: 2384663
[TBL] [Abstract][Full Text] [Related]
23. Diabetic BioBreeding/Worcester (BB/Wor) rats need not be lymphopenic.
Like AA; Guberski DL; Butler L
J Immunol; 1986 May; 136(9):3254-8. PubMed ID: 3485683
[TBL] [Abstract][Full Text] [Related]
24. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
[TBL] [Abstract][Full Text] [Related]
25. Ghrelin attenuates the development of acute pancreatitis in rat.
Dembinski A; Warzecha Z; Ceranowicz P; Tomaszewska R; Stachura J; Konturek SJ; Konturek PC
J Physiol Pharmacol; 2003 Dec; 54(4):561-73. PubMed ID: 14726611
[TBL] [Abstract][Full Text] [Related]
26. Prevention of autoimmune type I diabetes in biobreeding (BB) rats by a newly established, autoreactive T cell line from acutely diabetic BB rats.
Nagata M; Yoon JW
J Immunol; 1994 Oct; 153(8):3775-83. PubMed ID: 7930594
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
Yale JF; Grose M; Videtic GM; Marliss EB
Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
[TBL] [Abstract][Full Text] [Related]
28. Variable prevalence of lymphocytic thyroiditis among diabetes-prone sublines of BB/W or rats.
Rajatanavin R; Appel MC; Reinhardt W; Alex S; Yang YN; Braverman LE
Endocrinology; 1991 Jan; 128(1):153-7. PubMed ID: 1986916
[TBL] [Abstract][Full Text] [Related]
29. [Interleukin-2 modifies the development of insulin-dependent diabetes of BB rats].
Zielasek J; Burkart V; Kolb H
Immun Infekt; 1990 Apr; 18(2):55-6. PubMed ID: 2351412
[TBL] [Abstract][Full Text] [Related]
30. The effect of methimazole on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat.
Allen EM; Rajatanavin R; Nogimori T; Cushing G; Ingbar SH; Braverman LE
Am J Med Sci; 1986 Nov; 292(5):267-71. PubMed ID: 3777011
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous autoimmune thyroiditis in Bio Breeding/Worcester (BB/W) rat.
Yanagisawa M; Hara Y; Satoh K; Tanikawa T; Sakatsume Y; Katayama S; Kawazu S; Ishii J; Komeda K
Endocrinol Jpn; 1986 Dec; 33(6):851-61. PubMed ID: 3556149
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-2-dependent control of disease development in spontaneously diabetic BB rats.
Zielasek J; Burkart V; Naylor P; Goldstein A; Kiesel U; Kolb H
Immunology; 1990 Feb; 69(2):209-14. PubMed ID: 2307481
[TBL] [Abstract][Full Text] [Related]
33. Effect of iodine intake and methimazole on lymphocytic thyroiditis in the BB/W rat.
Braverman LE; Paul T; Reinhardt W; Appel MC; Allen EM
Acta Endocrinol Suppl (Copenh); 1987; 281():70-6. PubMed ID: 3475923
[TBL] [Abstract][Full Text] [Related]
34. The biobreeding Worcester rat--a model of organ-specific autoimmunity.
Allen EM; Braverman LE
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 3():7-10. PubMed ID: 8986410
[No Abstract] [Full Text] [Related]
35. The effect of ciamexone on lymphocytic thyroiditis and insulin-dependent diabetes mellitus in the BB/Wor rat.
Abend S; Cormier J; Appel MC; Lueprasitsakul W; Alex S; Mordes JP; Usadel KH; Handler ES; Rossini AA; Braverman LE
Immunopharmacology; 1990; 19(3):163-8. PubMed ID: 2394579
[TBL] [Abstract][Full Text] [Related]
36. The biological activity in vivo of recombinant murine interleukin 1 in the rat.
Tocco-Bradley R; Moldawer LL; Jones CT; Gerson B; Blackburn GL; Bistrian BR
Proc Soc Exp Biol Med; 1986 Jun; 182(2):263-71. PubMed ID: 3486424
[TBL] [Abstract][Full Text] [Related]
37. Low-dose IL-2 therapy for autoimmune diseases.
Collison J
Nat Rev Rheumatol; 2019 Jan; 15(1):2. PubMed ID: 30518787
[No Abstract] [Full Text] [Related]
38. Gene Expression Analysis of the Pre-Diabetic Pancreas to Identify Pathogenic Mechanisms and Biomarkers of Type 1 Diabetes.
Yip L; Fuhlbrigge R; Alkhataybeh R; Fathman CG
Front Endocrinol (Lausanne); 2020; 11():609271. PubMed ID: 33424774
[TBL] [Abstract][Full Text] [Related]
39. Long-term inhibition of dipeptidyl-peptidase 4 reduces islet infiltration and downregulates IL-1β and IL-12 in NOD mice.
He X; Li W; Xie Y; Zhao Y
Int Immunopharmacol; 2020 Nov; 88():106945. PubMed ID: 33182020
[TBL] [Abstract][Full Text] [Related]
40. Alpha cells, the main source of IL-1β in human pancreas.
Anquetil F; Sabouri S; Thivolet C; Rodriguez-Calvo T; Zapardiel-Gonzalo J; Amirian N; Schneider D; Castillo E; Lajevardi Y; von Herrath MG
J Autoimmun; 2017 Jul; 81():68-73. PubMed ID: 28325643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
